Eiger BioPharmaceuticals, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Eiger BioPharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2013 to Q4 2023.
  • Eiger BioPharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending December 31, 2023 was $360K, a 81.1% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $360K -$1.55M -81.1% Dec 31, 2023 10-K 2024-04-08
Q3 2023 $144K -$554K -79.4% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $790K -$4.29M -84.4% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1.07M -$3.84M -78.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.91M -$2.6M -57.7% Dec 31, 2022 10-K 2024-04-08
Q3 2022 $698K -$4.04M -85.3% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $5.08M +$993K +24.3% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $4.91M +$986K +25.1% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $4.51M +$607K +15.6% Dec 31, 2021 10-K 2023-03-17
Q3 2021 $4.74M +$959K +25.4% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $4.09M +$304K +8.04% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $3.92M +$140K +3.7% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $3.9M +$1.39M +55.4% Dec 31, 2020 10-K 2022-03-10
Q3 2020 $3.78M +$393K +11.6% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $3.78M +$1.18M +45.5% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $3.78M +$1.08M +39.7% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $2.51M +$2.08M +476% Dec 31, 2019 10-K 2021-03-09
Q3 2019 $3.39M +$3M +771% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $2.6M +$2.31M +796% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $2.71M +$2.42M +836% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $436K +$124K +39.7% Dec 31, 2018 10-K 2020-03-13
Q3 2018 $389K +$323K +489% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $290K +$209K +258% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 $289K +$165K +133% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 $312K +$169K +118% Dec 31, 2017 10-K 2019-03-14
Q3 2017 $66K -$76K -53.5% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $81K -$64K -44.1% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 $124K -$31K -20% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 $143K +$97K +211% Dec 31, 2016 10-K 2018-03-09
Q3 2016 $142K +$132K +1320% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 $145K +$18K +14.2% Jun 30, 2016 10-Q 2016-08-10
Q1 2016 $155K -$30K -16.2% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 $46K -$218K -82.6% Dec 31, 2015 10-K 2017-03-23
Q3 2015 $10K -$270K -96.4% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $127K -$22K -14.8% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 $185K +$174K +1582% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 $264K -$2.03M -88.5% Dec 31, 2014 10-K 2016-03-30
Q3 2014 $280K Sep 30, 2014 10-Q 2014-11-12
Q2 2014 $149K Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $11K Mar 31, 2014 10-Q 2014-05-13
Q4 2013 $2.3M Dec 31, 2013 10-K 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.